PubRank

Henri Agut

Author PubWeight™ 69.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 2007 5.58
2 Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007 2.27
3 Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. J Infect Dis 2005 2.03
4 From RNA to quasispecies: a DNA polymerase with proofreading activity is highly recommended for accurate assessment of viral diversity. J Virol Methods 2003 1.69
5 Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 2011 1.50
6 Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med 2014 1.45
7 Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity. AIDS 2006 1.43
8 A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 2013 1.41
9 Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol 2013 1.33
10 Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 2002 1.19
11 Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 2002 1.13
12 Herpes simplex encephalitis : from virus to therapy. Infect Disord Drug Targets 2011 1.05
13 Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 2003 1.03
14 HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. AIDS 2009 1.03
15 Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 2005 1.01
16 The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study. Int J Cancer 2011 1.00
17 Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother 2010 0.99
18 Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain. Virology 2010 0.97
19 Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection. Antiviral Res 2008 0.96
20 Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. J Clin Virol 2006 0.96
21 Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles. J Clin Virol 2007 0.92
22 Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir. J Infect 2005 0.92
23 Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir. Mol Pharmacol 2002 0.91
24 Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antiviral agents. Antimicrob Agents Chemother 2003 0.90
25 Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antiviral Res 2005 0.90
26 Variability of gB and gH genes of human herpesvirus-6 among clinical specimens. J Med Virol 2008 0.90
27 Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey. Antiviral Res 2013 0.89
28 Length variability of telomeric repeat sequences of human herpesvirus 6 DNA. J Virol Methods 2009 0.88
29 Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections: Evaluation on whole blood specimens and proficiency panels. J Virol Methods 2009 0.87
30 Quantitation of human herpesvirus-6A, -6B and -7 DNAs in whole blood, mononuclear and polymorphonuclear cell fractions from healthy blood donors. J Clin Virol 2011 0.87
31 Primary infection with a lamivudine-resistant hepatitis B virus. AIDS 2002 0.86
32 Quantitation of HHV-7 genome by real-time polymerase chain reaction assay using MGB probe technology. J Virol Methods 2002 0.86
33 Detection of a new variant of herpes simplex virus type 2 among HIV-1-infected individuals. J Clin Virol 2013 0.85
34 Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance. Antiviral Res 2004 0.83
35 Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies. J Acquir Immune Defic Syndr 2008 0.83
36 Detection of human herpesvirus 7 DNA in peripheral blood reflects mainly CD4+ cell count in patients infected with HIV. J Med Virol 2005 0.83
37 Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients. J Clin Microbiol 2002 0.82
38 Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis. J Clin Virol 2013 0.82
39 Molecular characterization of herpes simplex virus 2 strains by analysis of microsatellite polymorphism. J Clin Microbiol 2013 0.81
40 No influence of human herpesvirus 8 infection on the progression of HIV-1 infection in initially asymptomatic patients. AIDS 2003 0.81
41 Truncated forms of human and simian immunodeficiency virus in infected individuals and rhesus macaques are unique or rare quasispecies. Virology 2003 0.81
42 Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir. Antiviral Res 2011 0.81
43 Persistence of DNA in cell cultures may jeopardize the analysis of human herpesvirus 6 dynamics by means of real-time PCR. J Virol Methods 2005 0.81
44 Performance of the DiaSorin LIAISON(®) anti-HBs II for the detection of hepatitis B surface antibodies: comparison with the Abbott Architect anti-HBs assay. J Clin Virol 2011 0.80
45 Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection. PLoS One 2012 0.80
46 Clinical and microbiological evaluation of travel-associated respiratory tract infections in travelers returning from countries affected by pandemic A(H1N1) 2009 influenza. J Travel Med 2011 0.80
47 Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7. J Clin Microbiol 2002 0.80
48 Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor. Antiviral Res 2011 0.79
49 Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in Djibouti. J Med Virol 2002 0.79
50 Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature. Antivir Ther 2014 0.79
51 Different expression of human herpesvirus-6 (HHV-6) load in whole blood may have a significant impact on the diagnosis of active infection. J Clin Virol 2009 0.78
52 Polymorphonuclear leukocytes mainly contribute to human herpesvirus-6 load in the peripheral blood of patients. Clin Infect Dis 2006 0.78
53 Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection. J Clin Virol 2012 0.78
54 Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet. Antivir Ther 2007 0.77
55 Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation. J Clin Virol 2009 0.77
56 Impact of HIV-1 infection on herpes simplex virus type 2 genetic variability among co-infected individuals. J Med Virol 2014 0.77
57 Characterization of a cidofovir-resistant HHV-6 mutant obtained by in vitro selection. Antiviral Res 2008 0.77
58 Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity. Antiviral Res 2012 0.77
59 Is human herpesvirus-6 DNA in plasma the right marker for active infection? J Infect Dis 2006 0.76
60 Is human herpesvirus-7 a marker or a competitor for HIV progression? AIDS 2004 0.76
61 HDP-CDV as an alternative for treatment of human herpesvirus-6 infections. J Clin Virol 2012 0.76
62 No evidence for a major risk of roseolovirus vertical transmission during pregnancy. Clin Infect Dis 2003 0.76
63 Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factor. Antivir Ther 2009 0.76
64 Tenofovir Gel to Prevent HSV-2 Infection. N Engl J Med 2015 0.75
65 Human herpesvirus 6 genome integration: a possible cause of misdiagnosis of active viral infection? J Infect Dis 2006 0.75
66 Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1. J Med Virol 2012 0.75
67 Activity of H2G on human herpesvirus-6B strains either sensitive or resistant to ganciclovir. J Clin Virol 2010 0.75
68 Detection of pandemic (H1N1) 2009 virus in patients treated with oseltamivir. Emerg Infect Dis 2010 0.75
69 Roseolovirus DNA in the colonic mucosa of HIV-seropositive patients with diarrhea. Clin Infect Dis 2003 0.75
70 Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation. J Med Virol 2012 0.75
71 Structured treatment interruption for patients with human immunodeficiency virus infection. N Engl J Med 2003 0.75
72 Routine use of duplex real-time PCR assays including a commercial internal control for molecular diagnosis of opportunistic DNA virus infections. J Virol Methods 2012 0.75
73 Polymorphism of gp41 glycoprotein might influence the progression to disease in HIV-1 infection. AIDS 2013 0.75
74 [Herpes simplex virus meningitis in 11 patients]. Med Mal Infect 2008 0.75
75 Human Herpesviruses 6A, 6B, and 7. Microbiol Spectr 2016 0.75
76 Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development. Antiviral Res 2010 0.75
77 Hepatitis C virus infection in long-term nonprogressor HIV-1-infected subjects. J Acquir Immune Defic Syndr 2002 0.75
78 [Properties and diagnosis of Ebola virus]. Bull Acad Natl Med 2014 0.75